new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

B r a h m s Gmbh patents

Recent patent applications related to B r a h m s Gmbh. B r a h m s Gmbh is listed as an Agent/Assignee. Note: B r a h m s Gmbh may have other listings under different names/spellings. We're not affiliated with B r a h m s Gmbh, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | B r a h m s Gmbh-related inventors




Date B r a h m s Gmbh patents (updated weekly) - BOOKMARK this page
11/03/16Prognosis of adverse events in patients with suspected chronic heart failure
05/26/16Augurin immunoassay
05/12/16Method for risk stratification in stable coronary artery disease
04/07/16Csf diagnostic in vitro diagnosis of dementias and neuroinflammatory diseases
10/15/15Arginine vasopressin pro-hormone as predictive biomarker for diabetes
09/03/15Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin
04/30/15Biomarkers for the diagnosis, prognosis, assessment and therapy stratification of syncope
03/26/15Method for risk stratification in stable coronary artery disease
03/19/15Prediction of outcome in patients with chronic obstructive pulmonary disease
03/19/15Prognosis of adverse events in patients with suspected chronic heart failure
11/13/14Method of obtaining a binder to prepro-vasopressin or fragments thereof
10/30/14Determination of a midregional proadrenomedullin partial peptide in biological fluids for diagnostic purposes, and immunoassays for carrying out such a determination
08/28/14Molecular markers for urinary tract infections
08/14/14Diagnostic use of prosomatostatin
02/27/14Rare earth metal complex having phenanthroline compound as ligand
02/20/14Biomarkers for the prediction of incident cancer
11/14/13Prognosis and risk assessment of patients with non-specific complaints
05/16/13Method for the selective determination of procalcitonin 1-116
04/18/13Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with non-specific complaints
04/04/13Molecular markers for urinary tract infections
12/13/12Method for determining a marker in small volume of a sample of a bodily fluid
10/18/12Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a method
10/04/12Novel monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding to their variable regions, and their uses in diagnostic, preventive and therapeutic medicine
09/20/12Novel compounds having phenanthroline structure
06/14/12Procalcitonin for the prognosis of adverse events
05/24/12Diagnostical use of peroxiredoxin 4
05/17/12Immunoassay for the detection of procalcitonin
04/26/12Risk assessment for antibotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin
04/05/12Detection of bacterial infections in subjects suffering from dyspnea
03/29/12Use of carbamoyl phosphate synthetase 1 (cps) as a humoral biomarker for the diagnosis of tumour diseases and chronic inflammatory intestinal diseases
01/05/12In vitro- the diagnosis, prognosis, monitoring and therapy follow-up of disorders associated with the metabolic syndrome, a cardiovascular disease and/or insulin resistance
01/05/12Biomarker for the prediction of first adverse events
01/05/12Prognostic biomarkers for the progression of primary chronic kidney disease
12/29/11Arginine vasopressin pro-hormone as predictive biomarker for diabetes
10/27/11Methods and assays for classifying foodstuff and/or beverage and/or diet and/or nutrition regimen and/or medicament in view of an effect on the cardiovascular system
10/27/11Prognosis and risk assessment in stroke patients by determining the level of marker peptides
09/22/11Azurophilic granule proteases as markers in cardiological diseases
07/14/11Marker for graft failure and mortality
06/23/11Use of procalcitonin (pct) in risk stratification and prognosis of patients with a primary, non-infectious disease
05/12/11Pro-endothelin-1 for the prediction of impaired peak oxygen consumption
04/14/11Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with B r a h m s Gmbh in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for B r a h m s Gmbh with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';